Tango for Older People With Dementia

Effects of Tango on Older People With Dementia. Randomized Controlled Study.

Cognitive impairment (CI) is the leading cause of loss of autonomy and has a huge impact on physical performance and quality of life (QOL) in older people. Pharmacological treatments currently available have modest efficacy at best. Dance as both artistic and physical activity, combining emotions, social interaction, and sensory stimulation, therefore appears as a non-pharmacological intervention, which could contribute to the prevention of functional decline.

Among all the existing dances, tango occupies a special place because of the cultural and emotional resonance it carries, but also because of what it leads to motor mobilization (variations in the rhythm of walking, rotation of the belts, weight transfers…). These characteristics seem to make the tango an excellent tool for the rehabilitation of balance and gait, as well as for the prevention of the loss of autonomy in older adults with CI.

The objective of this study is to evaluate and compare the effectiveness of an intervention based on tango and classical physical activity.

Study Overview

• Status: Recruiting
• Conditions: Old Age; Dementia
• Intervention / Treatment: Other: Tango intervention; Other: Adapted Physical Activity

Detailed Description

CI is a major cause of loss of independence in older people. Alterations in balance and gait are very often present, these worsen the overall condition of the patient and are a sign of poor prognosis. Consequently, the quality of life of the patient and his family is severely affected. The pharmacological treatments currently available aim to alleviate the symptoms. Current data support the modest efficacy of these treatments at best. Non-pharmacological interventions (NPI) are key tools for improving physical performance, functional abilities, cognitive, psychological and social functioning. The benefits of NPIs are observed daily in the field. To be better known, recognized and deployed more widely, it is essential to evaluate their effects and their implementation in a scientific way by following the criteria of evidence-based medicine. Dancing is widely appreciated by older people. "It is both an artistic and physical activity that combines emotions, social interaction, sensory stimulation, thus creating enriched environmental conditions for the elderly". Tango in particular has been used as a therapeutic instrument for a long time. Its regular practice has benefits in many aspects of health and can have a positive impact on cognitive abilities, as it requires sustained attention. Studies on tango as a therapy in Parkinson's disease have shown its effectiveness in improving psychomotor and cognitive signs and especially in the quality of life. Numerous studies have demonstrated the benefits that dance-based interventions can bring, far outweighing the risk of falls they represent. From a motor point of view, tango is a moderate-intensity exercise in which static and dynamic postural control is stimulated. This dance, based on walking, proves to be an excellent tool for rehabilitation, prevention of falls, as well as for the prevention of functional decline in older people with CI.

Objectives: The general goal of this project is to analyze the effects of tango on physical abilities, gait and quality of life of older people with C

Secondary objectives:

• Evaluate the effectiveness of this type of program compared to traditional treatment.
• Refine the characteristics of effective management, concerning the dose, frequency, and duration of intervention.
• Analyze the effects of tango on the spatiotemporal parameters of walking.

General hypotheses: Various studies have highlighted the positive effects of tango face of different conditions, including Parkinson's disease. Based on these findings, the investigators hypothesize that tango interventions have a positive effect on physical abilities and quality of life in older adults with CI.

• Study Type: Interventional
• Enrollment (Anticipated): 124
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Renaud Jamet, Nurse; Phone Number: 4574 (0033)0472081896; Email: r.jamet@ch-montdor.fr
• Study Contact Backup: Name: Lucia Bracco, PhD Student; Phone Number: (0033)0786952449; Email: lucia.bracco@u-bourgogne.fr

Study Locations

• France
  • Albigny-sur-Saône, France
    • Completed
    • Centre Hospitalier du Mont d'Or
  • Chasselay, France, 69380
    • Recruiting
    • Ehpad Du Chg Le Val D'Or
    • Contact: Renaud Jamet, Nurse; Phone Number: 4574 (0033)0472081896; Email: r.jamet@ch-montdor.fr
    • Contact: Lucia Bracco, PhD Student; Phone Number: (0033)0786952449; Email: lucia.bracco@u-bourgogne.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Over 65 years old
• MMSE < 21
• agreed to participate
• lived permanently in the nursing home
• able to walk 10 meters without human assistance

Exclusion Criteria:

• medical contraindications,
• limited life expectancy
• bedridden persons.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Tango group; Tango intervention 2 times/week 1 hour During 3 months Conducted by care staff who previously received training in therapeutic tango from the University of Burgundy.	Other: Tango intervention; The interventions will be implemented by ABB Reportages and will be carried out by nursing staff who had previously received training in therapeutic tango at the University of Burgundy. A dance movement therapist and a musician will accompany the interventions twice a month. Participants will attend a 1-hour tango session, twice a week for twelve weeks.; Other Names: dance-movement-therapy
Active Comparator: Physical activity group; Physical activity intervention 2 times/week 1 hour During 3 months No music Conducted by physical activity professor assisted by care staff	Other: Adapted Physical Activity; The intervention will be carried out by an Adapted Physical Activity professor and by nursing staff. Music is prohibited during the sessions. Participants will attend a 1-hour APA, twice a week for twelve weeks.; Other Names: APA

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from Baseline physical abilities (balance, gait speed and lower limbs strength) at 1 and 3 months	Physical abilities will be measured with the Short Physical Performance Battery (SPPB). This test is composed of three evaluation criteria: balance, walking speed and sit to stand [23]. Specifically, during the balance test, the subject had to maintain each of three distinct positions for 10 seconds (feet together, semi-tandem and tandem). The failure of a step was the condition to start the second test, in which the subject walked 4 meters two consecutive times. The best score was retained. Finally, the time taken to complete the fastest 5 chair lifts without the help of the upper limbs was evaluated. At the end of the three tests, a score of a maximum of 12 points could be obtained.	Before intervention/ after 1 month / after 3 months
Change from Baseline general physical performance at 1 and 3 months	The Timed Up & Go test (TUG) is a general physical performance test used to assess mobility, balance and locomotor performance in elderly people with balance disturbances. The individual must stand up from a chair (which should not be leaned up against a wall), walk a distance of 3 meters, turn around, walk back to the chair and sit down - all performed at a comfortable and safe pace. One practice trial is permitted to allow the individual to familiarize him/herself with the task. Timing commences with the verbal instruction "go" and stops when the patient returns to seated position. The individual wears their regular footwear and is permitted to use their walking aid (cane/walker) with its use indicated on the data collection form. No physical assistance is given.	Before intervention/ after 1 month / after 3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from Baseline ability to perform activities of daily living (ADL) at 1 and 3 months	Ability to perform ADL will be measured using the Katz Index, consisting of a questionnaire assessing abilities in six activities of daily living (ADL): personal hygiene care, dressing, toilet use, locomotion, continence and eating. For each domain, the answer var-ies between: 1 (complete independence), 0.5 (partial independence) or 0 (absolute depend-ence). In total, an index of zero to six is obtained, where zero indicates the highest degree of dependence.	Before intervention/ after 1 month / after 3 months
Change from Baseline questionnaire on Quality of Life (QoL) at 1 and 3 months	QoL will be measured with the questionnaire Quality of Life in Alzheimer disease (QoL-AD).This questionnaire is administered directly to the participant, up to a severe stage of the disease, and to the main caregiver. The participant and caregiver ratings were combined into a weighted composite score: (2 × patient score + 1 × caregiver score)/3. Thus, the answers provided by the patient remain preponderant in this model. The QoL-AD comprises 13 items (physical health, energy, mood, living situation, memory, family, marriage, friends, self, ability to carry out daily tasks, ability to do things for fun, money and life as a whole). Response options include 1(poor), 2(fair), 3(good) and 4 (excellent), for a total score of 13-52, with higher scores indicating better QoL.	Before intervention/ after 1 month / after 3 months
Change from Baseline neuropsychiatric symptoms at 1 and 3 months	neuropsychiatric symptoms will be evaluated using the Neuropsychiatric Inventory-Questionnaire (NPI-Q), which is an informant-based interview that assesses neuropsychiatric symptoms of the participant. NPI consists of 10 (or 12) items that are assayed with questions, subquestions, and ratings of frequency and severity.	Before intervention/ after 1 month / after 3 months
Change from Baseline signs and symptoms of major depression at 1 and 3 months	Signs and symptoms of major depression will be assessed with the Cornell Scale for Depression in Dementia (CSDD), which is a 19-item clinician-administered instrument that uses information from interviews with both the patient and a nursing staff member, a method suitable for demented patients. The scale has high interrater reliability (kw = 0.67), internal consistency (coefficient alpha: 0.84), and sensitivity. Total Cornell Scale scores correlate (0.83) with depressive subtypes of various intensity classified according to Research Diagnostic Criteria.	Before intervention/ after 1 month / after 3 months

Collaborators and Investigators

• Sponsor: University of Burgundy
• Investigators: Principal Investigator: France Mourey, Professor, Inserm U1093, University of Burgundy

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2022
• Primary Completion (Anticipated): June 16, 2023
• Study Completion (Anticipated): September 29, 2023

Study Registration Dates

• First Submitted: February 8, 2023
• First Submitted That Met QC Criteria: February 22, 2023
• First Posted (Actual): February 24, 2023

Study Record Updates

• Last Update Posted (Actual): February 24, 2023
• Last Update Submitted That Met QC Criteria: February 22, 2023
• Last Verified: February 1, 2023

More Information

Terms related to this study

• Keywords: gait; quality of life; older adults; well-being; physical performance; cognitive impairment; dance movement therapy; tango-therapy
• Additional Relevant MeSH Terms: Mental Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurocognitive Disorders; Dementia
• Other Study ID Numbers: CERUBFC-2022-09-29-031

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No